{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T06:30:04Z","timestamp":1766212204731,"version":"3.48.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-025-00677-z","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T05:12:09Z","timestamp":1766207529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rare CD138 negative plasma cell leukemia with pleomorphic morphology\u2014CD319 to the rescue when traditional markers fail"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0127-851X","authenticated-orcid":false,"given":"Richa","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selvan","family":"P.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmita","family":"Dass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoranjan","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"issue":"12","key":"677_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1182\/bloodadvances.2016003715","volume":"1","author":"M Roshal","year":"2017","unstructured":"Roshal M, Flores-Montero JA, Gao Q, Koeber M, Wardrope J, Durie BGM et al (2017) MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods. Blood Adv 1(12):728\u2013732","journal-title":"Blood Adv"},{"issue":"8","key":"677_CR2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1200\/JCO.19.01231","volume":"38","author":"B Paiva","year":"2020","unstructured":"Paiva B, Puig N, Cedena MT, Rosi\u00f1ol L, Cord\u00f3n L, Vidriales MB et al (2020) Measurable residual disease by next-generation flow cytometry in multiple myeloma. J Clin Oncol 38(8):784\u2013792","journal-title":"J Clin Oncol"},{"key":"677_CR3","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1182\/blood-2013-09-529800","volume":"123","author":"I Frigyesi","year":"2014","unstructured":"Frigyesi I, Adolfsson J, Ali M, Christophersen MK, Johnsson E, Turesson I et al (2014) Robust isolation of malignant plasma cells in multiple myeloma. Blood 123:1336\u20131340","journal-title":"Blood"},{"issue":"3","key":"677_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3892\/ijo.2012.1545","volume":"41","author":"Y Kawano","year":"2012","unstructured":"Kawano Y, Fujiwara S, Wada N et al (2012) Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. Int J Oncol 41(3):876\u2013884","journal-title":"Int J Oncol"},{"issue":"1","key":"677_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pathol.2021.09.011","volume":"54","author":"S El Hussein","year":"2022","unstructured":"El Hussein S, Medeiros LJ, Hu S, Lin P, Wang W (2022) The many faces of plasma cell neoplasms: morphological and immunophenotypical variants of the great imitator. Pathology 54(1):32\u201342","journal-title":"Pathology"},{"key":"677_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41375-019-0519-4","volume":"34","author":"I Akhmetzyanova","year":"2020","unstructured":"Akhmetzyanova I, McCarron MJ, Parekh S et al (2020) Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination. Leukemia 34:245\u2013256","journal-title":"Leukemia"},{"issue":"11","key":"677_CR7","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1182\/blood.2019001845","volume":"134","author":"W Shuai","year":"2019","unstructured":"Shuai W, Li S (2019) CD138- plasma cell myeloma. Blood 134(11):906","journal-title":"Blood"},{"issue":"8","key":"677_CR8","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/medicina60081351","volume":"60","author":"I Seili-Bekafigo","year":"2024","unstructured":"Seili-Bekafigo I, Torlakovic E, Grenko Malnar T, Dami\u0107 MS, Prka \u017d, Matu\u0161an Ilija\u0161 K, Had\u017eisejdi\u0107 I (2024) Atypical plasma cell leukemia mistaken for acute leukemia: a case report. Medicina (Kaunas) 60(8):1351","journal-title":"Medicina (Kaunas)"},{"key":"677_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccr.2013.08.009","volume":"24","author":"C Leung-Hagesteijn","year":"2013","unstructured":"Leung-Hagesteijn C, Erdmann N, Cheung G, Keats JJ, Stewart AK, Reece DE et al (2013) Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma. Cancer Cell 24:289\u2013304","journal-title":"Cancer Cell"},{"issue":"11","key":"677_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232233","volume":"12","author":"AF Setiadi","year":"2019","unstructured":"Setiadi AF, Sheikine Y (2019) CD138-negative plasma cell myeloma: a diagnostic challenge and a unique entity. BMJ Case Rep 12(11):e232233","journal-title":"BMJ Case Rep"},{"key":"677_CR11","doi-asserted-by":"crossref","unstructured":"Soh KT, Tario JD Jr., Hahn T, Hillengass J, McCarthy PL, Wallace PK (2021) CD319 (SLAMF7) an alternative marker for detecting plasma cells in the presence of daratumumab or elotuzumab. Cytometry B Clin Cytom 100(4):497\u2013508","DOI":"10.1002\/cyto.b.21961"},{"issue":"16","key":"677_CR12","doi-asserted-by":"publisher","first-page":"1654374","DOI":"10.3389\/fimmu.2025.1654374","volume":"20","author":"JE Sander","year":"2025","unstructured":"Sander JE, Han I, Fickenscher L, Schmidt JP, Kroll H, Vosikova T et al (2025) SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8\u207a T cells to immune checkpoint blockade. Front Immunol 20(16):1654374","journal-title":"Front Immunol"},{"issue":"1","key":"677_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80971-5","volume":"14","author":"H Kared","year":"2024","unstructured":"Kared H, Tan C, Narang V, Tan SW, Xian CH, Wei AT et al (2024) SLAMF7 defines subsets of human effector CD8 T cells. Sci Rep 14(1):30779","journal-title":"Sci Rep"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00677-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00677-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00677-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T05:12:09Z","timestamp":1766207529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00677-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["677"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00677-z","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No authors\u2019 identifiable name or institution must be cited mention): not identifiable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not taken as no identifiable information included in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}